| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Follitropin delta |
| Brand | Rekovelle® |
| Indication | For controlled ovarian stimulation (COS) for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle. |
| Assessment Process | |
| Rapid review commissioned | 25/07/2017 |
| Rapid review completed | 15/08/2017 |
| Rapid review outcome | Full pharmacoeconomic assessment recommended at submitted price. |
Reimbursement approved following new price application – February 2019.
